#1 Clinical Trials Search in Europe

Doxycycline Hyclate

Doxycycline Hyclate, a versatile antibiotic, is being studied in several clinical trials for its effectiveness in treating various medical conditions. This article explores the ongoing research on Doxycycline Hyclate, highlighting its potential applications in acne, sexually transmitted infections, thyroid-associated ophthalmopathy, and other disorders. We’ll examine the different dosages, administration methods, and comparative studies to provide a comprehensive overview of this drug’s role in current medical research.

Table of Contents

What is Doxycycline Hyclate?

Doxycycline Hyclate is an antibiotic medication that belongs to the tetracycline class of drugs. It is widely used to treat various bacterial infections and has anti-inflammatory properties. Doxycycline Hyclate is known by several other names, including Doryx, Vibramycin, Doxine, and simply doxycycline[1][2].

Uses of Doxycycline Hyclate

Doxycycline Hyclate is prescribed for a variety of conditions due to its effectiveness against different types of bacteria. Some of the main uses include:

  • Acne vulgaris: A common skin condition characterized by pimples, blackheads, and whiteheads
  • Sexually transmitted infections (STIs): Particularly chlamydia and sometimes used for prevention
  • Respiratory tract infections: Such as pneumonia or bronchitis
  • Periodontal disease: Infections of the gums and supporting structures of the teeth
  • Certain eye conditions: Including some types of inflammation

Doxycycline for Acne Treatment

Doxycycline Hyclate is commonly used to treat moderate to severe acne vulgaris. Clinical trials have shown its effectiveness in reducing inflammatory acne lesions (red, swollen pimples) and improving overall skin appearance[1][3].

In one study, researchers compared the effectiveness of different dosages of doxycycline for acne treatment. They found that a lower dose of 20 mg twice daily (known as a sub-antimicrobial dose) could be as effective as the standard 100 mg twice daily dose, potentially reducing the risk of antibiotic resistance[4].

Another study compared the effectiveness of doxycycline to spironolactone, a hormone-based treatment, for acne in women. This research aims to find alternatives to long-term antibiotic use for acne treatment[5].

Doxycycline for STI Prevention

Recent research has explored the use of doxycycline for preventing sexually transmitted infections (STIs), particularly in high-risk populations. A clinical trial called DISCO (Doxycycline Intervention for STI ChemoprophOlaxis) is investigating whether taking doxycycline can help prevent bacterial STIs such as chlamydia, gonorrhea, and syphilis in men who have sex with men (MSM)[6].

The study compares two approaches:

  1. STI PrEP (Pre-Exposure Prophylaxis): Taking 100 mg of doxycycline daily
  2. STI PEP (Post-Exposure Prophylaxis): Taking 200 mg of doxycycline within 24-72 hours after a sexual encounter deemed risky

This research could potentially provide a new tool for STI prevention in high-risk populations[6].

Other Conditions Treated with Doxycycline

Doxycycline Hyclate has shown promise in treating various other conditions:

  • Thyroid-Associated Ophthalmopathy: A condition affecting the eyes in some people with thyroid disorders. A study is investigating whether doxycycline can help reduce inflammation and swelling in the eyes[7].
  • Heart Protection After Heart Attacks: Researchers are studying whether doxycycline can help protect heart muscle after a heart attack by inhibiting certain proteins that can cause damage during recovery[8].
  • Oral Mucositis in Cancer Patients: A study is looking at whether low doses of doxycycline can prevent or reduce mouth sores (oral mucositis) in patients undergoing chemotherapy for leukemia[2].

Dosage and Administration

The dosage of Doxycycline Hyclate varies depending on the condition being treated:

  • For acne: Doses can range from 20 mg to 100 mg twice daily, depending on the severity and the doctor’s recommendation[1][4].
  • For STI treatment: Typically 100 mg twice daily for 7 days[9].
  • For STI prevention (in clinical trials): 100 mg daily or 200 mg after potential exposure[6].

Doxycycline is usually taken orally in the form of tablets or capsules. It’s important to follow your doctor’s instructions carefully and complete the full course of treatment, even if you start feeling better before it’s finished.

Side Effects and Safety

Like all medications, Doxycycline Hyclate can cause side effects. Common side effects may include:

  • Nausea or vomiting
  • Diarrhea
  • Skin sensitivity to sunlight
  • Headache

More serious side effects are rare but can occur. It’s important to discuss potential risks and side effects with your healthcare provider before starting treatment[1][5].

Doxycycline should not be used in children under 8 years old or in pregnant women, as it can affect bone and tooth development in growing children and fetuses.

Condition Dosage Administration Key Findings/Objectives
Acne Vulgaris 20-100 mg daily Oral tablets Comparing efficacy of subantimicrobial doses to standard doses; comparing to spironolactone in women
Bacterial STIs (Chlamydia) 100-200 mg daily Oral tablets/capsules Evaluating efficacy in treating and preventing STIs; comparing different formulations
Thyroid Associated Ophthalmopathy 100 mg daily Oral tablets Assessing effectiveness in reducing eye muscle and fat volume
Cutaneous Schwannoma (NF2) Varies Direct injection into tumor Investigating potential to reduce tumor size
Oral Mucositis in Leukemia Patients 50 mg daily Oral tablets Evaluating prevention of oral mucositis during chemotherapy

FAQ

  • What conditions is Doxycycline Hyclate being studied for in clinical trials? Doxycycline Hyclate is being studied for various conditions including acne vulgaris, bacterial sexually transmitted infections (STIs) like chlamydia, thyroid-associated ophthalmopathy, and as a preventive measure for STIs in high-risk populations.
  • How is Doxycycline Hyclate administered in these trials? The administration varies depending on the study. It's typically given orally in tablet or capsule form, with dosages ranging from 20mg to 200mg daily. Some trials use it as a daily preventive measure, while others use it after potential exposure to infections.
  • Are there any unique applications of Doxycycline Hyclate being explored? Yes, some unique applications include using sub-antimicrobial doses for acne treatment to reduce antibiotic resistance, injecting it directly into cutaneous schwannomas in neurofibromatosis type 2 patients, and using it as a chemoprophylaxis for STIs in high-risk populations.
  • How does Doxycycline Hyclate compare to other treatments in these trials? Several trials are comparing Doxycycline Hyclate to other treatments. For example, it's being compared to spironolactone for acne in women, and different formulations of Doxycycline are being compared for efficacy in treating chlamydia infections.
  • What are the potential benefits of using Doxycycline Hyclate in these conditions? Potential benefits include its anti-inflammatory properties for conditions like acne and thyroid-associated ophthalmopathy, its effectiveness against bacterial infections, and its potential to prevent STIs when used as a prophylactic measure. Some studies also explore its use in lower doses to minimize side effects and antibiotic resistance.

Ongoing Clinical Trials on Doxycycline Hyclate

  • Study of Azithromycin, Doxycycline, and Sodium Ascorbate for Patients with Early-Stage Breast Cancer

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on Preventing Infections After Abdominal Surgery Using D-PLEX with Doxycycline Hyclate for Patients Undergoing Abdominal Surgery

    Not recruiting

    3 1 1
    Investigated drugs:
    Germany Hungary Ireland Italy Poland Portugal +1

Glossary

  • Acne Vulgaris: A common skin condition characterized by the appearance of pimples, blackheads, and whiteheads, typically on the face, chest, and back.
  • Chlamydia Trachomatis: A common sexually transmitted bacterial infection that can affect both men and women, often without noticeable symptoms.
  • Thyroid Associated Ophthalmopathy: An eye condition associated with thyroid disorders, characterized by inflammation and swelling of the tissues around the eyes.
  • Subantimicrobial Dose: A dose of an antibiotic that is lower than the amount typically used to treat infections, often used for its anti-inflammatory properties.
  • Chemoprophylaxis: The use of medication to prevent disease or infection before exposure or during periods of high risk.
  • Microbiological Cure: The elimination of a specific microorganism (such as bacteria) from the body, as confirmed by laboratory tests.
  • Investigator Global Assessment (IGA): A standardized scale used by researchers to evaluate the overall severity of a condition, often used in dermatology studies.
  • Cutaneous Schwannoma: A benign tumor that develops from the cells that form the protective covering of nerves, occurring in or under the skin.
  • Neurofibromatosis Type 2 (NF2): A genetic disorder characterized by the growth of noncancerous tumors in the nervous system, particularly affecting the auditory nerves.
  • Nucleic Acid Amplification Test (NAAT): A laboratory technique used to detect and identify microorganisms by amplifying and detecting their genetic material.

References

  1. https://clinicaltrials.gov/study/NCT00635609
  2. https://clinicaltrials.gov/study/NCT01087476
  3. https://clinicaltrials.gov/study/NCT01301586
  4. https://clinicaltrials.gov/study/NCT05399290
  5. https://clinicaltrials.gov/study/NCT04582383
  6. https://clinicaltrials.gov/study/NCT04762134
  7. https://clinicaltrials.gov/study/NCT05112211
  8. https://clinicaltrials.gov/study/NCT03508232
  9. https://clinicaltrials.gov/study/NCT01113931